A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis
Part of paid clinical trials in Shreveport, Louisiana.
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT04877990
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Deucravacitinib — DRUGSpecified dose on specified days
Study Details
The purpose of this study is to evaluate the long-term safety and efficacy of Deucravacitinib in participants who have previously been enrolled in a Deucravacitinib Phase 2 study for moderate to severe Crohn's disease or moderate to severe Ulcerative Colitis.
Key Dates
- Start date
- May 7, 2021
- Status verified
- Aug 2024
- Primary completion
- Aug 29, 2023
- Completion
- Aug 29, 2023
Study Design
- Enrollment
- 67 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Long-Term Extension Rollover Study: Deucravacitinib
Primary Outcome Measure
Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Treatment Emergent Serious Adverse Events (TESAEs) [ Time Frame: From first dose to 30 days post last dose (Up to 110 weeks) ]
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Local Institution - 0036 | Shreveport | Louisiana | 71105 | - |
| Local Institution - 0002 | Wyoming | Michigan | 49519 | - |
| Local Institution - 0037 | Jackson | Mississippi | 39216 | - |
| Local Institution - 0041 | Cleveland | Ohio | 44195 | - |
| Local Institution - 0038 | Pittsburgh | Pennsylvania | 15213 | - |
| Local Institution - 0066 | Charleston | South Carolina | 29425 | - |
| Local Institution - 0053 | Garland | Texas | 75044 | - |
| Local Institution - 0056 | San Antonio | Texas | 78229 | - |
| Local Institution - 0049 | Tyler | Texas | 75701 | - |
| Local Institution - 0055 | Richmond | Virginia | 23249 | - |
Find similar trials in Shreveport, LA
By condition
Related Studies
- Fecal Microbiome TransplantPHASE1 · Enrolling By Invitation · Judith Kelsen · Philadelphia, Pennsylvania
- Improving the Quality of Care for Adults With Inflammatory Bowel DiseaseEnrolling By Invitation · Dartmouth-Hitchcock Medical Center · Los Angeles, California
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF TherapyPHASE1/PHASE2 · Recruiting · Children's Hospital Medical Center, Cincinnati · Hartford, Connecticut